Those results of this study provide a new mechanism for the role of PADI4 in GC metastasis and provide a reasonable explanation for the correlation between the high expression of PADI4 and clinical stage of gastric cancer, suggesting that PADI4 may become a potential therapeutic target for advanced gastric cancer. The gene discussed is PADI4; the disease is gastric cancer.